This is a Phase 1/1b open-label, multi-center dose escalation and dose optimization study designed to evaluate the safety and preliminary efficacy of IAM1363 i…

HER2 Mutation-Related TumorsHER2HER2-positive Breast Cancer+10 more

~Estimated

~$10 – $8,750

Iambic Therapeutics, IncNCT06253871

Phase 1

Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy

The purpose of this study is to determine if the radiotracer, \[68Ga\]Ga-ABY-025, used for PET imaging can help us better identify and visualize lesions or tum…

Locally Advanced CancerMetastatic CancerHER2+2 more

~Estimated

~$10 – $6,250

Vanderbilt-Ingram Cancer CenterNCT06828588